AVDL
Avadel Pharmaceuticals
AVDL
AVDL
83 hedge funds and large institutions have $217M invested in Avadel Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
24% less capital invested
Capital invested by funds: $284M → $217M (-$67.8M)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
98% less call options, than puts
Call options by funds: $8K | Put options by funds: $433K
Holders
83
Holding in Top 10
1
Calls
$8K
Puts
$433K
Top Buyers
| 1 | +$27.1M | |
| 2 | +$6.91M | |
| 3 | +$4.15M | |
| 4 |
Renaissance Technologies
New York
|
+$2.63M |
| 5 |
DM
Deerfield Management
New York
|
+$2.46M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$10.3M | |
| 3 | -$8.01M | |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$7.35M |
| 5 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$6.28M |